Skip to content

Effect of High Intensity Interval Training and Ultrasound Cavitation on Lipid Profile in Type 2 Diabetes Patients

Combined Effect of High Intensity Interval Training and Ultrasound Cavitation on Lipid Profile in Type 2 Diabetes Patients With Abdominal Obesity

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06926725
Acronym
Diabeties
Enrollment
66
Registered
2025-04-15
Start date
2025-04-11
Completion date
2026-02-01
Last updated
2025-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 2

Brief summary

The study aim to find out the combined effect of high intensity interval training and ultrasound cavitation on lipid profile in type two diabetic patient with abdominal obesity.

Detailed description

study aim to find out the combined effect of high intensity interval training and ultrasound cavitation on lipid profile in type two diabetic patient with abdominal obesity.Type two diabetic patients with abdominal obesity , randomly assigned into 3 equal groups: 66 patients 1. study group (A) 22 patients : They will receive ultrasound cavitation , HIIT and diatery advice . 2. study group (B) 22 patients : They will receive HIIT and diatery advice . 3. control group 22 patients They will only receive diatery advice.

Interventions

DEVICECavitation : Study group A only will receive one session per week for three months (total 12 sessions ). Ultrasound treatments are performed using an applicator head with diameter 7 cm . Intensity :

Cavitation : Study group A only will receive one session per week for three months (total 12 sessions ). Ultrasound treatments are performed using an applicator head with diameter 7 cm . Intensity : 0.1-0.5 w/cm2 (low) Frequency : 30-40 KHZ (low) Duration : 30 minutes

OTHERhigh intenisty exercise

type: alternate high intensity exercise (aerobic or strength training) with recovery stages Intensity: high intensity (75%-95% HRmax) or RPE(14-16 hard to very hard ) ( according to patient tolerance), followed by active or passive recovery stage (30%-60% HRmax) or RPE(7-11 extremely light to light) . frequency : 3 days per week for three months (with no more than 2 consecutive days between sessions) Duration: 10 seconds to 4 minutes high intensity ,12 seconds to 5 minutes active or passive recovery .(according to patient tolerance) 5 minutes warm up pre exercise . 5 minutes cool down post exercise . Progress gradually. total duration :20-40 minutes (according to patient tolerance and progression)

DIETARY_SUPPLEMENTDiet

In all groups (both study groups A&B and control group).

Sponsors

Mahmoud Awad Ramadan Elkholy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Type two diabetic patients with abdominal obesity , randomly assigned into 3 equal groups: 66 patients 1. study group (A) 22 patients : They will receive ultrasound cavitation , HIIT and diatery advice . 2. study group (B) 22 patients : They will receive HIIT and diatery advice . 3. control group 22 patients They will only receive diatery advice.

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient with type 2 diabetes. * waist circumference \>102 cm in male ,\>88 cm in female * lipid profile range will be (between border line and high risk ).

Exclusion criteria

Kidney disease Heart disease Lung disease ,Liver disease ,Neurological disorders ,Pregnant women , breast feeding, immune deficiency , cancer Heavy smoker

Design outcomes

Primary

MeasureTime frameDescription
Anthropometric Measurements3 monthsIt will be performed before and after the treatment . Weight in (kg) is measured by in body scale During the measurement of height in( cm) patient is barefoot . Body mass index (BMI): weight (kg)/ \[ height (m)\] 2
Lipid profile3 monthscontains (cholesterol, triglycerides, Low-density lipoprotein cholesterol (LDL), and high-density lipoprotein cholesterol (HDL)).

Countries

Egypt

Contacts

Primary ContactMahmoud awd elkholy, lecturer of physical therapy
elkholym774@gmail.com00201125746573

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026